Dare Bioscience, Inc.

Nasdaq:DARE

Pharmaceutical Preparations·SAN DIEGO, CA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/31/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
10-Q	Q2 2024	6/30/24	8/12/24	→
↓

Earnings Releases (8-K)

16 shown

Filed	Period
11/13/25	Q4 FY2025	→
8/14/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
3/31/25	Q1 FY2025	→
11/14/24	Q4 FY2024	→
8/12/24	Q3 FY2024	→
↓

News (8-K)

64 shown

Filed	Type	Description
3/9/26	Other	Unregistered Sales of Equity Securities	→
3/2/26	Reg FD	Regulation FD Disclosure	→
1/29/26	Other	Unregistered Sales of Equity Securities	→
1/6/26	Reg FD	Regulation FD Disclosure	→
12/1/25	Reg FD	Termination of a Material Definitive Agreement	→
9/2/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
8/14/25	S-8	S-8	→
4/24/25	ARS	ARS	→
11/26/24	424B3	424B3	→
11/15/24	S-1	S-1	→
5/10/24	424B5	424B5	→
5/1/24	424B3	424B3	→
↓

Filing History(721 filings)

TypeDateAccessionPeriodSize

8-K

Mar 9, 2026

0001493152-26-0093648-K

Mar 6, 2026

193.1 KB

8-K

Mar 2, 2026

0001493152-26-0084518-K

Mar 2, 2026

22.2 MB

Feb 20, 2026

0001199102-26-000004FORM 4

Feb 18, 2026

8.5 KB

Feb 2, 2026

0001199102-26-000002FORM 4

Jan 30, 2026

5.5 KB

Feb 2, 2026

0001535596-26-000002FORM 4

Jan 30, 2026

5.5 KB

8-K

Jan 29, 2026

0001493152-26-0042458-K

Jan 23, 2026

943.2 KB

253G1

Jan 7, 2026

0001493152-26-000804253G1

—

621.3 KB

8-K

Jan 6, 2026

0001493152-26-0005138-K

Jan 6, 2026

9.9 MB

QUALIF

Jan 5, 2026

9999999994-26-000005

—

1.9 KB

1-A/A

Dec 29, 2025

0001493152-25-029450

—

1.7 MB

SCHEDULE 13G/A

Dec 23, 2025

0002089796-25-000002

—

6.2 KB

8-K

Dec 1, 2025

0001493152-25-0254918-K

Nov 26, 2025

257.4 KB

1-A

Nov 25, 2025

0001493152-25-024997

—

888.5 KB

10-Q

Nov 13, 2025

0001401914-25-00005010-Q

Sep 30, 2025

11.5 MB

8-K

Nov 13, 2025

0001493152-25-0222778-K

Nov 13, 2025

288.2 KB

SCHEDULE 13G

Oct 6, 2025

0002089796-25-000001

—

7.0 KB

Sep 4, 2025

0001401914-25-000046FORM 4

Sep 4, 2025

5.6 KB

8-K

Sep 2, 2025

0001493152-25-0125168-K

Sep 2, 2025

19.2 MB

S-8

Aug 14, 2025

0001493152-25-011992S-8

—

243.6 KB

10-Q

Aug 14, 2025

0001401914-25-00004410-Q

Jun 30, 2025

7.0 MB

8-K

Aug 14, 2025

0001641172-25-0239718-K

Aug 14, 2025

333.0 KB

8-K

Jul 25, 2025

0001493152-25-0114028-K

Jul 25, 2025

195.7 KB

8-K

Jul 21, 2025

0001641172-25-0202958-K

Jul 18, 2025

200.5 KB

8-K

Jul 14, 2025

0001641172-25-0188948-K

Jul 14, 2025

240.8 KB

Jul 10, 2025

0001401914-25-000040FORM 4

Jul 9, 2025

5.5 KB

25 filings shown

Filed	Form	Description
6/12/25	DEFA14A	DEFA14A	→
4/24/25	DEFA14A	DEFA14A	→
4/24/25	DEF 14A	DEF 14A	→
4/26/24	DEFA14A	DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→
4/16/24	PRE 14A	PRE 14A	→
↓

Dare Bioscience, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(721 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/20/26	4	4	→
2/2/26	4	4	→
2/2/26	4	4	→
9/4/25	4	4	→
7/10/25	4	4	→
7/10/25	4	4	→
↓

Filed	Form	Description
1/7/26	253G1	253G1	→
1/5/26	QUALIF	QUALIF	→
12/29/25	1-A/A	1-A/A	→
12/23/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/25/25	1-A	1-A	→
10/6/25	SCHEDULE 13G	SCHEDULE 13G	→
↓